| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 4,889,000 | 6,703,000 | 4,265,000 | 4,063,000 | | Cost of Revenue | 3,741,000 | 5,355,000 | 3,266,000 | 3,096,000 | | | Gross Profit | 1,148,000 | 1,348,000 | 999,000 | 967,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| (203,000) | | Selling General and Administrative | 904,000 | 1,075,000 | 845,000 | 953,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 244,000 | 273,000 | 154,000 | 217,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 16,000 | 52,000 | 35,000 | 12,000 | | Earnings Before Interest And Taxes | 260,000 | 314,000 | 200,000 | 229,000 | | Interest Expense | 12,000 | 11,000 | 17,000 | 21,000 | | Income Before Tax | 248,000 | 303,000 | 183,000 | 208,000 | | Income Tax Expense | 69,000 | 80,000 | 59,000 | 46,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 177,000 | 225,000 | 119,000 | 158,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 177,000 | 225,000 | 119,000 | 158,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $177,000 | $225,000 | $119,000 | $158,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
